Using beta-blockers to treat heart failure

Timothy Nguyen; Ahmed Shaheed; Srikanth Venigalla; Emanuel Mullokandov

doi:10.1097/01.JAA.0000450813.21330.ee

Using beta-blockers to treat heart failure

JAAPA. 2014 Dec;27(12):50-5. doi: 10.1097/01.JAA.0000450813.21330.ee.

Authors

Timothy Nguyen¹, Ahmed Shaheed, Srikanth Venigalla, Emanuel Mullokandov

Affiliation

¹ Timothy Nguyen is an associate professor of pharmacy practice at Long Island University's Arnold and Marie Schwartz College of Pharmacy and Health Sciences in Brooklyn, N.Y., and an adjunct clinical pharmacology professor in Long Island University's PA program and at St. Peter's University in New Jersey. Ahmed Shaheed, Srikanth Venigalla, and Emanuel Mullokandov are doctor of pharmacy candidates at Long Island University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

PMID: 25417667
DOI: 10.1097/01.JAA.0000450813.21330.ee

Abstract

Bisoprolol, carvedilol, metoprolol, and nebivolol are beta-blocker drugs used to improve survival in patients with systolic heart failure. This article reviews these drugs and how practitioners can initiate and titrate them for maximum patient benefit.

Publication types

Review

MeSH terms

Adrenergic beta-Antagonists / administration & dosage
Adrenergic beta-Antagonists / therapeutic use*
Dose-Response Relationship, Drug
Heart Failure / drug therapy*
Humans

Substances

Adrenergic beta-Antagonists